Epidemiological and clinical features of COVID-19 patients in Saudi Arabia. 2021

Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
Global Center of Mass Gatherings Medicine, Ministry of Health, P. O. Box 8320, Riyadh 13314, Saudi Arabia. Electronic address: ahalalahmari@moh.gov.sa.

BACKGROUND The aim of this study is to describe the clinical and demographic characteristics of COVID-19 patients, and the risk factors associated with death in Saudi Arabia to serve as a reference to further understand this pandemic and to help in the future decisions and control of this global crisis. METHODS This multicenter, retrospective, observational, cross-sectional study was conducted on 240,474 patients with confirmed COVID-19 in Saudi Arabia. Data was collected retrospectively through the Health Electronic Surveillance Network at the Ministry of Health. Patients were classified based on their outcome as recovered, dead, or active with no definite outcome. We must specify the date period. RESULTS As of 20th of June 2020, 79.7% of COVID-19 cases were young and middle-aged, ranging between 20-59 years. There was evidently a difference in the sex ratio, where males constituted 71.7% of cases. The majority were non-Saudi nationals, representing 54.7% of cases. Furthermore, the contraction of COVID-19 was travel-related in 45.1% of cases. Signs and symptoms were reported in 63% of cases, the most common of which were fever; 85.2%, and cough; 85%. Deaths occurred more frequently in patients 40-49 years, 50-59 years, and 60-69 years, representing 19.2%, 27.9%, and 21.3% of deaths, respectively. Additionally, the case fatality rate (CFR) was higher in older age-groups, reaching 10.1% in those ≥80 years. Moreover, the CFR of males was higher than that of females, with 0.95% and 0.62%, respectively. As for nationality, Saudis had a CFR of 0.46% versus 1.19% in non-Saudis. CONCLUSIONS The total number of positive COVID-19 cases detected constitute 0.7% of the Saudi population to date. Older age, non-Saudi nationalities, being male, travelling outside Saudi Arabia, and the presence of symptoms, as opposed to being asymptomatic were considered risk factors and found to be significantly more associated with death in patients with COVID-19.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19

Related Publications

Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
October 2021, Saudi medical journal,
Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
January 2023, Frontiers in cardiovascular medicine,
Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
July 2021, Medicine,
Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
January 2023, Infection and drug resistance,
Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
December 2021, Cureus,
Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
November 2020, European journal of medical research,
Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
August 2021, Journal of infection and public health,
Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
January 2020, PloS one,
Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
February 2023, Public health,
Ahmed A Alahmari, and Anas A Khan, and Ahmed Elganainy, and Emad L Almohammadi, and Ahmed M Hakawi, and Abdullah M Assiri, and Hani A Jokhdar
September 2022, International journal of pediatrics & adolescent medicine,
Copied contents to your clipboard!